L. Evans

ICOSL+ plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonist

E. Rickel, Hao Liu, S. Dillon, 2020, Science Translational Medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains

E. Rickel, S. Dillon, S. Peng, 2017, Frontiers in Immunology.

Systemic Administration of Acazicolcept, a Dual CD28 and Inducible T cell Costimulator Inhibitor, Ameliorates Experimental Autoimmune Uveitis

Kathryn L. Pepple, S. Dillon, K. Lewis, 2023, Translational vision science & technology.

Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101) Reveals Non-Redundant Roles of T Cell Co-Stimulation Pathways in Inflammatory Arthritis.

S. Dillon, S. Mudri, S. Peng, 2023, Arthritis & rheumatology.

Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B Lymphocytes and Pathogenic Autoantibodies for the Treatment of Lupus and Other B Cell–Related Autoimmune Diseases

S. Dillon, S. Mudri, S. Peng, 2023, Arthritis & rheumatology.

Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains

E. Rickel, S. Dillon, S. Peng, 2020, Frontiers in Immunology.

Non‐Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN‐101)

S. Dillon, S. Mudri, S. Peng, 2023 .